APOE and Alzheimer disease: While some studies suggest that ApoE4 AD carriers have a faster rate of cognitive decline (Craft et al., 1998; Martins et al., 2005; Schmidt et al., 2012), others suggest no association (Growdon et al., 1996; Kleiman et al., 2006).